Journal article

Changes in biodistribution on Ga-68-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression

Martin H Cherk, Grace Kong, Rodney J Hicks, Michael S Hofman

Cancer Imaging | E-MED | Published : 2018

DOI: 10.1186/s40644-018-0136-x

Citation metrics

12Web of Science
11Scopus

Keywords

Middle Aged
Neuroendocrine Tumour
Neoplasm Metastasis
Toxicity
Affinity
Radiopharmaceuticals
Ga-68
Aged
Positron Emission Tomography Computed Tomography
Radiology, Nuclear Medicine & Medical Imaging
Science & Technology
Male
Neuroendocrine Tumors
Octreotate
Positron Emission Tomography
Female
Somatostatin
Humans
Organometallic Compounds
Lu-177-Octreotate
Life Sciences & Biomedicine
Dotatate
Tissue Distribution
Adult
Octreotide
Oncology
Guidelines
Pet/ct
Receptor Radionuclide Therapy
False Positive Reactions